US2007128710A1PendingUtilityA1
Novel protein associated with cell stress response
Est. expiryApr 8, 2019(expired)· nominal 20-yr term from priority
C12Q 1/6886C07K 14/47C12Q 2600/158
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A stress-phosphorylated endoplasmic reticulum protein, Nogo B, is provided. The protein is hyperphosphorylated as a result of exposure of cells to stress. Two transcripts of Nogo B are identified in human tissues, and the longer transcript is predominant in human brain tumor samples.
Claims
exact text as granted — not AI-modified1 . A purified polypeptide, the amino acid sequence of which comprises a sequence at least 90% identical to SEQ ID NO:2, or an immunogenic fragment thereof.
2 . The purified polypeptide of claim 1 , the amino acid sequence of which comprises a sequence at least 95% identical to SEQ ID NO:2.
3 . The purified polypeptide of claim 1 , the amino acid sequence of which comprises a sequence at least 98% identical to SEQ ID NO:2.
4 . The purified polypeptide of claim 1 , the amino acid sequence of which comprises a sequence at least 99% identical to SEQ ID NO:2.
5 . The purified polypeptide of claim 1 , the amino acid sequence of which comprises SEQ ID NO:2.
6 . The purified polypeptide of claim 1 , the amino acid sequence of which consists of SEQ ID NO:2
7 . The purified polypeptide of claim 1 , comprising up to 10 conservative amino acid substitutions, insertions or deletions.
8 . The purified polypeptide of claim 7 , comprising up to 10 conservative amino acid substitutions.
9 . The purified polypeptide of claim 7 , comprising up to 5 conservative amino acid substitutions.
10 . The purified polypeptide of claim 1 , comprising up to 7 conservative amino acid substitutions.
11 . The purified polypeptide of claim 1 , wherein phosphorylation of the polypeptide is increased during cellular stress.
12 . The purified polypeptide of claim 11 , wherein the cellular stress is one or more of ultraviolet irradiation, DNA damage, osmotic stress, ionic stress, or oxidative stress.
13 . The polypeptide of claim 1 , wherein the polypeptide binds specifically to an antibody that binds specifically to Nogo B.
14 . The antibody of claim 13 , wherein the antibody is a monoclonal antibody, a polyclonal antibody, a chimeric antibody, a human antibody, a humanized antibody, a single-chain antibody, or a Fab fragment.
15 . The purified polypeptide of claim 1 , the amino acid sequence of which comprises amino acids 2-373 of SEQ ID NO:2.
16 . A purified polypeptide comprising:
(a) amino acids 1-197 of SEQ ID NQ:2; and (b) amino acids 236-373 of SEQ ID NO:2, wherein the amino acid residue corresponding to residue 197 of SEQ ID NO: 2 is joined by a peptide bond to the amino acid residue corresponding to residue 236 of SEQ ID NO:2.
17 . A purified polypeptide comprising:
(a) amino acids 1-288 of SEQ ID NO:2; and (b) amino acids 336-373 of SEQ ID NO:2, wherein the amino acid residue corresponding to residue 288 of SEQ ID NO:2 is joined by a peptide bond to the amino acid residue corresponding to residue 336 of SEQ ID NO:2.
18 . A purified polypeptide comprising:
(a) amino acids 1-197 of SEQ ID NO:2; and (b) amino acids 236-288 of SEQ ID NO:2; and (c) amino acids 336-373 of SEQ ID NO:2; wherein the amino acid residue corresponding to residue 197 of SEQ ID NO:2 is joined by a peptide bond to the amino acid residue corresponding to residue 236 of SEQ ID NO:2, and the amino acid residue corresponding to residue 288 of SEQ ID NO: 2 is joined by a peptide bond to the amino acid residue corresponding to residue 336 of SEQ ID NO:2.Join the waitlist — get patent alerts
Track US2007128710A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.